Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients

針對症狀 Hepatocellular Carcinoma
臨床試驗編號 NCT00699816
臨床階段 Phase III
臨床試驗位址 5 Study Locations
目前研究進度 This study has been completed.
試驗開始日期 June 17, 2008
試驗開始日期 December 14, 2012
臨床目的 To prove that the efficacy and safety of 'INNOCELL* Immuncell-LC group' is superior to 'non-treatment group' in patient undergone curative resection (PEIT, RFA or operation) for hepatocellular carcinoma in Korea
http://www.clinicaltrial.gov/ct2/show/NCT00699816?term=innocell&rank=2